166 related articles for article (PubMed ID: 22268180)
1. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation.
Krishnan P; Fiel MI; Rosenkrantz AB; Hajdu CH; Schiano TD; Oyfe I; Taouli B
AJR Am J Roentgenol; 2012 Feb; 198(2):370-6. PubMed ID: 22268180
[TBL] [Abstract][Full Text] [Related]
2. Fontan-associated liver disease: Spectrum of US findings.
Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
[TBL] [Abstract][Full Text] [Related]
3. Hepatoportal sclerosis in childhood: a mimic of extrahepatic portal vein obstruction.
Carson JA; Tunell WP; Barnes P; Altshuler G
J Pediatr Surg; 1981 Jun; 16(3):291-6. PubMed ID: 7252729
[TBL] [Abstract][Full Text] [Related]
4. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation.
Vilgrain V; Condat B; Bureau C; Hakimé A; Plessier A; Cazals-Hatem D; Valla DC
Radiology; 2006 Oct; 241(1):149-55. PubMed ID: 16908681
[TBL] [Abstract][Full Text] [Related]
5. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI.
Kang JH; Kim DH; Kim SY; Kang HJ; Lee JB; Kim KW; Lee SS; Choi J; Lim YS
Abdom Radiol (NY); 2021 May; 46(5):1891-1903. PubMed ID: 33095310
[TBL] [Abstract][Full Text] [Related]
6. [Differential diagnosis of congenital fibrosis of the liver and hepatoportal sclerosis].
Radzhabova NI; Mansurov KhKh; Mirodzhov GK
Klin Med (Mosk); 2003; 81(1):67-9. PubMed ID: 12650101
[TBL] [Abstract][Full Text] [Related]
7. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis.
Isabel Fiel M; Thung SN; Hytiroglou P; Emre S; Schiano TD
Am J Surg Pathol; 2007 Apr; 31(4):607-14. PubMed ID: 17414109
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.
Feuerlein S; Boll DT; Gupta RT; Ringe KI; Marin D; Merkle EM
AJR Am J Roentgenol; 2011 Jan; 196(1):W18-24. PubMed ID: 21178026
[TBL] [Abstract][Full Text] [Related]
9. Characteristic MR and CT imaging findings of hepatobiliary paragonimiasis and their pathologic correlations.
Lu CY; Hu YJ; Chen WX
Acta Radiol; 2012 Jun; 53(5):481-4. PubMed ID: 22661601
[TBL] [Abstract][Full Text] [Related]
10. Hepatoportal sclerosis in childhood: descriptive analysis of 12 patients.
Cantez MS; Gerenli N; Ertekin V; Güllüoğlu M; Durmaz Ö
J Korean Med Sci; 2013 Oct; 28(10):1507-11. PubMed ID: 24133357
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dynamic contrast enhanced MRI and Doppler ultrasound in the pre-operative assessment of the portal venous system.
Naik KS; Ward J; Irving HC; Robinson PJ
Br J Radiol; 1997 Jan; 70():43-9. PubMed ID: 9059294
[TBL] [Abstract][Full Text] [Related]
12. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
Schiano TD; Kotler DP; Ferran E; Fiel MI
Am J Gastroenterol; 2007 Nov; 102(11):2536-40. PubMed ID: 17640321
[TBL] [Abstract][Full Text] [Related]
13. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
Attal P; Vilgrain V; Brancatelli G; Paradis V; Terris B; Belghiti J; Taouli B; Menu Y
Radiology; 2003 Aug; 228(2):465-72. PubMed ID: 12819340
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic utility of hepatic hemodynamics study in hepatoportal sclerosis].
Alonso S; Bañares R; Barrio J; Rincón D; Nuñez O; Alvárez E; Vaquero J; de Diego A
Gastroenterol Hepatol; 2001 Dec; 24(10):473-7. PubMed ID: 11730614
[TBL] [Abstract][Full Text] [Related]
15. Obliterative portal venopathy: findings at CT imaging.
Glatard AS; Hillaire S; d'Assignies G; Cazals-Hatem D; Plessier A; Valla DC; Vilgrain V
Radiology; 2012 Jun; 263(3):741-50. PubMed ID: 22474672
[TBL] [Abstract][Full Text] [Related]
16. [Hepatoportal sclerosis--special variant of liver cirrhosis].
Radzhabova NI; Maksumova ZI
Ter Arkh; 1986; 58(2):67-71. PubMed ID: 2939585
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
18. [Hepatoportal sclerosis associated with portal vein thrombosis in children: report of 3 cases].
Hessel G; Escanhoela CA; de Oliveira AD; De-Maria HK; Onishi E; Yamada RM; Ferreira AG
Arq Gastroenterol; 1997; 34(2):121-5. PubMed ID: 9496428
[TBL] [Abstract][Full Text] [Related]
19. [Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti].
Oberti F; Rifflet H; Fléjou JF; Leclech C; Belghiti J; Rousselet MC; Calès P
Gastroenterol Clin Biol; 1997; 21(2):147-51. PubMed ID: 9161481
[TBL] [Abstract][Full Text] [Related]
20. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
